Lanean...
Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia
PURPOSE: To evaluate the efficacy and safety of 500 mg of nemonoxacin administered orally once daily to outpatients with community-acquired pneumonia (CAP). PATIENTS AND METHODS: Patients with CAP who received nemonoxacin monotherapy were selected from outpatients who visited the Department of Pulmo...
Gorde:
| Argitaratua izan da: | Infect Drug Resist |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7337426/ https://ncbi.nlm.nih.gov/pubmed/32669862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S248092 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|